JPRN-UMIN000000762已完成未知
Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus - Compassionate open study of Rituximab in Systemic lupus Erythematosus
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Proteinuria>1.0g/24hr 2)APS complication 3)Pregnant women or lactating mothers 4)Positive HIV, HCV, HBs, HBc etc.
研究者
相似试验
已完成
2 期
A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)Diffuse large B-cell lymphomaJPRN-UMIN000001050Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)40
进行中（未招募）
不适用
Efficacy of Rituximab treatment in patients with rheumatoid arthritis having inadequate response to TNF blockerTo investigate the efficacy of treatment with Rituximab (MabThera®) in patients with active RA whose current treatment with one or more TNF-blocker (Etanercept - Enbrel®, Infliximab – Remicade® or Adalimumab - Humira®) alone or in combination with MTX is insufficient measured by DAS28 activity index.EUCTR2006-004673-98-HURoche (Hungary) Ltd.20
已完成
不适用
Phase II study of rituximab in patients with severe systemic lupus erythematosusSystemic lupus erythematosusJPRN-UMIN000000763Zenyaku Kogyo Co., Ltd.30
进行中（未招募）
不适用
Phase II Trial of Rituximab Plus 2CdA in Patients with Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)ymphoma of the Mucosa-Associated Lymphoid Tissue (MALT)MedDRA version: 9.1Level: LLTClassification code 10060707Term: MALT lymphomaEUCTR2008-000767-41-ATArbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH
招募中
2 期
Safety and Efficacy of Rituximab in patients with juvenile dermatomyositisJuvenile dermatomyositisJuvenile dermatomyositis.M33.0IRCT20231119060108N1Shahid Beheshti University of Medical Sciences7